Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 32,017 | 5 | 7 | 1,501 | 6,387 |
| Gross Profit | 32,017 | 5 | 7 | 1,501 | 6,387 |
| Operating Expenses | 25,798 | 23,985 | 21,511 | 20,861 | 19,519 |
| Operating Income | 6,219 | -23,980 | -21,504 | -19,360 | -13,132 |
| Other Income | -794 | 1,311 | -886 | 452 | 56 |
| Pre-tax Income | 5,425 | -22,669 | -22,390 | -18,908 | -13,076 |
| Income Tax | N/A | N/A | N/A | 0 | -85 |
| Net Income Continuous | 5,425 | -22,669 | -22,390 | -18,908 | -12,991 |
| Net Income | $5,425 | $-22,669 | $-22,390 | $-18,908 | $-12,991 |
| EPS Basic Total Ops | 0.16 | -0.67 | -0.69 | -0.60 | -0.41 |
| EPS Basic Continuous Ops | 0.16 | -0.67 | -0.68 | -0.60 | -0.41 |
| EPS Diluted Total Ops | 0.16 | -0.67 | -0.69 | -0.60 | -0.41 |
| EPS Diluted Continuous Ops | 0.16 | -0.67 | -0.68 | -0.60 | -0.41 |
| EPS Diluted Before Non-Recurring Items | 0.16 | -0.67 | N/A | N/A | N/A |
| EBITDA(a) | $6,618 | $-23,559 | $-21,020 | $-18,882 | $-12,769 |